VanEck Associates
AXNX

VanEck Associates’s Axonics, Inc. Common Stock AXNX Stock Holding History

VanEck Associates’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,957
Closed -$138K – 1439
2024
Q3 		$138K Sell
1,957
-406
-17% -$27.8K ﹤0.01% 1225
2024
Q2 		$159K Buy
2,363
+76
+3% +$5.12K ﹤0.01% 1211
2024
Q1 		$158K Buy
2,287
+95
+4% +$6.41K ﹤0.01% 1204
2023
Q4 		$136K Sell
2,192
-373
-15% -$20.9K ﹤0.01% 1207
2023
Q3 		$144K Buy
2,565
+99
+4% +$5.57K ﹤0.01% 1185
2023
Q2 		$124K Buy
2,466
+26
+1% +$1.38K ﹤0.01% 1214
2023
Q1 		$133K Buy
2,440
+386
+19% +$22.6K ﹤0.01% 1210
2022
Q4 		$128K Buy
+2,054
New +$136K ﹤0.01% 1209

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

VanEck Associates's AXNX Position: Q4 2024 in Review

VanEck Associates sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 1,957 shares — an estimated $138K sold.

VanEck Associates first reported a position in AXNX in Q4 2022 and held it in 8 quarters. The position peaked at $159K in Q2 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • VanEck Associates reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • VanEck Associates sold 1,957 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $138K.
  • VanEck Associates first reported a position in Axonics, Inc. Common Stock in Q4 2022 and held it in 8 quarters.
  • VanEck Associates's Axonics, Inc. Common Stock position peaked at $159K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.